Skip to content

Insider · CIK 0001859997

Patel Priti

Reports to the SEC for 1 company · SEATTLE, WA

Transactions

14

Companies

1

Filings

7

CIK

0001859997

Forms 4 and 5

Insider transactions

14 trades
DateCompanyValue
2023-04-03NGNENeurogene Inc.S Sale−$2,607.771
2023-03-31NGNENeurogene Inc.M Exercise/Conversion—
2023-03-31NGNENeurogene Inc. · Restricted Stock UnitsM Exercise/Conversion—
2023-02-02NGNENeurogene Inc.S Sale−$8,587.736
2023-02-01NGNENeurogene Inc.M Exercise/Conversion—
2023-02-01NGNENeurogene Inc. · Restricted Stock UnitsM Exercise/Conversion—
2022-08-02NGNENeurogene Inc. · Stock Option (Right to Buy)A Award—
2022-05-02NGNENeurogene Inc.S Sale−$6,748.607
2022-04-30NGNENeurogene Inc.M Exercise/Conversion—
2022-04-30NGNENeurogene Inc. · Restricted Stock UnitsM Exercise/Conversion—
2022-02-01NGNENeurogene Inc. · Restricted Stock UnitsA Award—
2021-08-03NGNENeurogene Inc. · Stock Option (Right to Buy)A Award—
2021-04-30NGNENeurogene Inc. · Restricted Stock UnitsA Award—
2021-04-30NGNENeurogene Inc. · Stock Option (Right to Buy)A Award—

Recent filings

7

Companies

1

Address

C/O NEOLEUKIN THERAPEUTICS, INC. 188 EAST BLAINE STREET, #450

SEATTLE, WA, 98102